Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal Journal arrow
arrow-active-down-2
Institution
1
Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal Journal arrow
arrow-active-down-2
Institution
1
Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Export
Sort by: Relevance
Interventions to improve executive functions in children aged 3years and under: A systematic review.

Early executive functioning (EF) skills are foundational capabilities that predict school readiness, academic development and psychiatric risk. Early interventions enhancing these capabilities could have critical import in improving outcomes. However, to develop interventions, it is necessary to identify specific EF skills that will vary with child age. Thus, we aimed to examine the characteristics and efficacy of interventions targeting EF in infancy and early childhood up to age 3. A comprehensive search of PubMed, Embase, CINAHL and APA PsycINFO databases was performed for studies published before December 2022. Randomized and non-randomized studies of interventions designed to improve at least one EF skill in children ≤3years were included. EF skills included attentional control, inhibition/self-regulation, activity initiation, working memory, cognitive flexibility, planning ability, problem-solving and performance monitoring. We independently extracted data, used the revised Cochrane Risk-of-Bias tool to assess the quality of the evidence and conducted Synthesis Without Meta-analysis (SWiM). The overall quality of the evidence and the strength of recommendations was determined using elements of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Thirty-five studies met inclusion criteria (original n= 7467). Studies were highly variable in the EF skill targeted, target subject (i.e., child, parent and teacher), nature and dosage of the intervention, and timing of outcome assessment. Most interventions focused on improving impulse control and self-regulation. The overall quality of evidence was low to moderate with a high risk of bias, though six studies had low risk of bias but yielded mixed findings of efficacy. The relatively small number of early EF intervention studies uses such variable methods that there is currently no converging evidence of efficacy to recommend a specific intervention. Thus, findings support the need for a more systematic, targeted approach to the design and implementation of early EF interventions for target populations.

Read full abstract
Open Access Icon Open Access
Clinical effects of a novel deep learning-based rehabilitation application on cardiopulmonary function, dynamic and static balance, gait function, and activities of daily living in adolescents with hemiplegic cerebral palsy.

Adolescents with hemiplegic cerebral palsy undergo conventional physical therapy (CPT) to improve static and dynamic balance, activities of daily living and cardiopulmonary function. To overcome this problem, we developed an innovative deep learning-based rehabilitation application (DRA) to provide a motivational and chaffed platform for such individuals. DRA evaluates the patients' functional abilities and diagnosis an appropriate therapeutic intervention like CPT. We compared the effects of DRA and CPT on 6-minute walking test (6 MWT), Borg rating of perceived exertion scale, Berg balance scale, functional ambulation category, and modified Barthel index in adolescents with hemiplegic cerebral palsy. A convenience sample of 30 adolescents with hemiplegic cerebral palsy was randomized into either the DRA or CPT group. DRA and CPT were administered to the participants, with each session lasting 30 minutes and apportioned thrice a week for a total of 4 weeks. Analysis of variance was performed and the level of significance was set at P < .05. The analysis indicated that DRA showed therapeutic effects on 6 MWT, Berg balance scale, and modified Barthel index compared to CPT. Our results provide evidence that DRA can improve cardiopulmonary function, balance, and activities of daily living more effectively than CPT in adolescents with hemiplegic cerebral palsy.

Read full abstract
Open Access Icon Open Access
USO DE TOXINA BOTULÍNICA EM PACIENTES PEDIÁTRICOS COM PARALISIA CEREBRAL EM 2022 NO BRASIL

Introdução: A paralisia cerebral é uma desordem crônica de déficit não progressivo do desenvolvimento motor causada por diferentes fatores etiológicos. Objetivo: Analisar o uso de toxina botulínica como uma abordagem terapêutica para o tratamento de paralisia cerebral em pacientes pediátricos. Metodologia: Trata-se de um estudo epidemiológico transversal que utilizou dados do SIA-PA do DATASUS, analisando crianças até 14 anos com diagnóstico de paralisia cerebral em 2022. Foram considerados variáveis do estudo o mês, região, faixa etária, raça/cor, sexo e tipo de atendimento. Foi utilizado o Software R para a análise dos dados. Resultados: Ao longo do ano, 12.695 crianças foram atendidas, evidenciando uma prevalência na faixa etária de 5 a 9 anos, de raça/cor branca e do sexo masculino. Análises temporais indicaram variações sazonais nos atendimentos, com maior prevalência entre agosto e setembro para crianças de 0 a 4 anos e, em abril e julho para o grupo de 5 a 9 anos, com maior concentração nas categorias quadriplégica espástica, diplégica espástica e hemiplégica espástica. Quanto ao uso da toxina botulínica, este foi mais proeminente na faixa etária de 5 a 9 anos. Conclusão: Os resultados deste estudo oferecem uma compreensão sobre o perfil de atendimento a pacientes pediátricos com paralisia cerebral no Brasil que fazem uso de toxina botulínica. A análise das unidades de toxina botulínica utilizadas em diferentes subcategorias ressaltou a importância de adaptações personalizadas no tratamento, considerando as necessidades específicas de cada perfil de paciente, especialmente na faixa etária de 5 a 9 anos.

Read full abstract
Open Access Icon Open Access